ADAPTIN BIO, INC. financial data

Location
Charlotte, NC
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 14 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1% %
Debt-to-equity -308% % -3155%
Return On Equity 246% % 105%
Return On Assets -118% % 100%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 8,455,829 shares 69%
Common Stock, Shares, Outstanding 8,455,829 shares 69%
Entity Public Float $0 USD
Common Stock, Value, Issued $846 USD 69%
Weighted Average Number of Shares Outstanding, Basic 8,455,829 shares 160%
Weighted Average Number of Shares Outstanding, Diluted 8,455,829 shares 160%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense $778,664 USD 14%
General and Administrative Expense $2,525,896 USD 377%
Operating Income (Loss) $2,140,494 USD -68%
Nonoperating Income (Expense) $247,374 USD
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $1,675,612 USD -51%
Net Income (Loss) Attributable to Parent $1,694,990 USD 26%
Earnings Per Share, Basic 0 USD/shares 41%
Earnings Per Share, Diluted 0 USD/shares 41%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $579,089 USD
Assets, Current $45,539 USD 11884%
Assets $322 USD -15%
Accounts Payable, Current $1,338,076 USD
Accrued Liabilities, Current $522,476 USD
Liabilities, Current $1,860,552 USD 690%
Liabilities $1,860,552 USD 690%
Retained Earnings (Accumulated Deficit) $7,923,783 USD -3260%
Stockholders' Equity Attributable to Parent $881,078 USD 73%
Liabilities and Equity $322 USD -15%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $2,279,876 USD -2442%
Net Cash Provided by (Used in) Financing Activities $4,620,020 USD 5033%
Common Stock, Shares Authorized 50,000,000 shares 0%
Common Stock, Shares, Issued 8,455,829 shares 69%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $579,089 USD 402%
Interest Paid, Excluding Capitalized Interest, Operating Activities $9,584 USD
Deferred Tax Assets, Valuation Allowance $85,817 USD 142%
Deferred Tax Assets, Gross $85,817 USD 142%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10,000,000 shares 0%
Unrecognized Tax Benefits $112,155 USD
Additional Paid in Capital $7,041,859 USD
Preferred Stock, Shares Outstanding 0 shares
Share-based Payment Arrangement, Expense $320,125 USD
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%